(Q42550139)

English

In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections

scientific article published on August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections (English)

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

gram-positive bacteria

0 references

Ellie J. C. Goldstein

1

object named as

Ellie J C Goldstein

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Kerin L. Tyrrell

4

object named as

Kerin L Tyrrell

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Diane M. Citron

2

object named as

Diane M Citron

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

C. Vreni Merriam

5

object named as

C Vreni Merriam

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

3

object named as

Yumi A Warren

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

author name string

Helen T Fernandez

6

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

50

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

8

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

2875-2879

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

28 May 2018

The emergence of infections with community-associated methicillin resistant Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

28 May 2018

Methicillin-resistant Staphylococcus aureus in community-acquired skin infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

28 May 2018

High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

28 May 2018

Antistaphylococcal activity of dalbavancin, an experimental glycopeptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

28 May 2018

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

28 May 2018

Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

28 May 2018

Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

16 August 2018

Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

16 August 2018

Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

16 August 2018

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

16 August 2018

Economic costs of diabetes in the US in 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

16 August 2018

In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

16 August 2018

Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1538693

16 August 2018

Patterns of foot examination in a diabetes clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/16870792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.00286-06

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42550139&oldid=2068568307"